Smallest Cas9 Ortholog Reported

Researchers demonstrate the delivery of AAV-packaged CRISPR-CjCas9 into the muscles and eyes of mice.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Comparison of Cas9 “gene scissors” from different bacteria: Streptococcus pyogenes, Staphylococcus aureus, and Campylobacter jejuni.INSTITUTE FOR BASIC SCIENCEAn ortholog to Streptococcus pyogenes Cas9 (SpCas9), Campylobacter jejuni Cas9 (CjCas9) is composed of just 984 amino-acid residues, making it the smallest such RNA-guided endonuclease characterized to date, according to researchers at the Institute for Basic Science in Seoul, who published their findings in Nature Communications this week (February 22).

The researchers packaged CRISPR-CjCas9 into an adeno-associated viral (AAV) vector, which they then injected into the muscles and eyes of mice. To demonstrate CjCas9’s capabilities, they used the system to modify a mouse gene linked to blindness. “CjCas9 is highly specific and does not cause off-target mutations in the genome,” coauthor Jin-Soo Kim of the Institute for Basic Science said in a statement.

“The researchers noted that CjCas9 designed to target six different DNA regions cleaved between one and 27 sites in the human and mouse genomes, suggesting that it is specific,” GenomeWeb reported. “By comparison, SpCas9”—made up of 1,368 amino acids and derived from Streptococcus pyogenes—“cleaved some 15 to 147 sites.”

The specificity of CjCas9could have clinical implications, the authors wrote. In their paper, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies